We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Abbott Demonstrates Core Diagnostics Solutions Consisting of Innovative Systems, Automation and Informatics at AACC 2021

By LabMedica International staff writers
Posted on 29 Sep 2021

Abbott Diagnostics (Lake Bluff, IL, USA) displayed its leading-edge technology at the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo with demonstrations of its innovative systems, automation and informatics. More...

Abbott’s innovative solutions on display at AACC 2021 included Alinity Systems, total laboratory automation and AliniQ Informatics and Professional Services. The company also showed how labs can create an agile strategy with The Abbott Transformation System and the invaluable answers that it placed in the hands of doctors, clinicians and caregivers at the Point of Care.

Abbott’s Alinity family comprises next-generation systems across immunoassay, clinical chemistry, point of care, hematology, blood and plasma screening and molecular diagnostics. On display at the event were the Alinity ci-series integrated clinical chemistry & immunoassay system, Alinity c clinical chemistry system, ALINITY I immunoassay system, and the Alinity m fully integrated, automated, high-throughput molecular diagnostics analyzer. Each Alinity system includes a number of features to help institutions, clinicians and laboratorians better navigate through a pressure-packed health care environment. Designed with universal, intuitive interfaces as well as common software and hardware, Abbott's Alinity systems have the ability to work together, providing greater capacity and simplifying the user experience. Several of the platforms are designed to run more tests in less space, generate test results faster and minimize human errors.

At AACC 2021, Abbott also highlighted its synergistic suite of automation and high volume end-to-end solutions that deliver seamless productivity across the entire laboratory. This included the ACCELERATOR a3600 total laboratory automation system that provides the power and flexibility to meet the needs of the laboratory, both today and in the future. Combined with informatics and lean principles, the ACCELERATOR a3600 maximizes efficiency by providing consistent, predictable sample management and helps improve patient care by minimizing opportunities for error.

Additionally, Abbott demonstrated how its AlinIQ suite of professional services can help labs uncover intelligent insights from their laboratory data and discover greater operational productivity with existing resources. For instance, Abbott’s The AlinIQ Always On services deliver predictive alerts to labs, enabling the detection and prevention of instrument downtime up to three days in advance. The AlinIQ AMS (Analyzer Management System) provides labs and hospital networks the ability to integrate different software systems into a single standardized platform to optimize sample processing time, workflow efficiency and quality results. Similarly, the AlinIQ BIS (Business Intelligence System) provides the tools to optimize throughput and capacity of existing systems to help labs absorb volume increases without additional budget. By delivering intelligent insights, AlinIQ BIS helps labs improve operations and operational expense performance and communicate the lab's value to the broader health care organization. The AlinIQ IMS (Inventory Management System), which combines innovative RFID technology and streamlined process consulting, allows labs to get ahead of operational needs, helping avoid shortages of critical items, reduce waste and time taken for manual processes.

Related Links:
Abbott Diagnostics


Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Urine Chemistry Control
Dropper Urine Chemistry Control
Clinical Chemistry System
P780
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: USU chemists Kadin Crosby, Bamidele Filani, and Ryan Jackson have reported newly discovered functions of CRISPR-Cas12a3 (Photo courtesy of USU/M. Muffoletto)

CRISPR Discovery Paves Way for Single Diagnostic Test for COVID, Flu and RSV

Immune systems across all forms of life defend against viruses by blocking their ability to replicate. Many CRISPR-based defenses achieve this by cutting viral DNA, but these approaches can damage host... Read more

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more

Pathology

view channel
Image: AI models combined with DOCI can classify thyroid cancer subtypes (Photo courtesy of T. Vasse et al., doi 10.1117/1.BIOS.3.1.015001)

AI-Powered Label-Free Optical Imaging Accurately Identifies Thyroid Cancer During Surgery

Thyroid cancer is the most common endocrine cancer, and its rising detection rates have increased the number of patients undergoing surgery. During tumor removal, surgeons often face uncertainty in distinguishing... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.